Answers are grounded in this paper and cite their sources.
Sarcoma biology has been the foundation of our understanding the molecular, immunologic, and viral bases of cancer.In the premodern era of orthopaedics, before arthroplasty and arthroscopy, bone and soft tissue sarcoma research established basic concepts of cancer biology.Virtually every major advance in our understanding of how genetic code aberrations cause cancer originated in investigations of sarcoma.Retinoblastoma gene and osteogenic sarcoma [1,4], Rous sarcoma virus (src gene) [7], Harvey and Kirsten sarcoma viruses (H-ras and V-ras) [8], and Li-Fraumeni syndrome (p53) [6], are important examples.Despite these contributions, during the last quarter-century most serious investigators focused on liquid (hematopoietic) cancers and eschewed the more difficult solid tumors.Because sarcomas-particularly bone sarcomas-are so rare, many investigators historically were deterred from working on musculoskeletal tumors.However, technologic advances in gene and nucleic acid sequencing, polymerase chain reaction, gene array platforms, si-RNA, and other experimental approaches allow us to probe the elusive causes of and treatment for sarcoma.The discovery of specific targeted therapy against Gastrointestinal Stromal Tumor (GIST) transformed the field [2].In cancer research, sarcoma is relevant again.There has been a resurgence of interest in the molecular basis of sarcoma.
No takes yet. Share an insight, caveat, or question.
Healey et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: